• KOLs Community
    • Bnt162B2
    • Bnt162B2 Vaccine
    • Haim Ben‐zvi
    • Haim Ben‐Zvi

      Haim Ben‐Zvi

      Rabin Medical Center, Microbiology lab, Petah Tikva, Israel | Microbiology Laboratory, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel | Microbiology lab, Rabin ...



      KOL Resume for Haim Ben‐Zvi


      Rabin Medical Center, Microbiology lab, Petah Tikva, Israel


      Microbiology Laboratory, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel


      Microbiologic Laboratory, Rabin Medical Center, Petah Tiqva, Israel


      Microbiology Laboratory, Rabin Medical Center, Beilinson Hospital, Petach-Tikva, Israel.

      Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel


      Microbiology Laboratories, Beilinson Hospital, Rabin Medical Center, Petah‐Tikva, Israel

      Laboratory of microbiology, Rabin Medical Center


      Microbiology Laboratory, Rabin Medical Centre, Beilinson Hospital, Petach-Tikva, Israel


      Department of Otorhinolaryngology and Head and Neck Surgery, and, Medical Laboratory, Rabin Medical Center, Petah Tikva, and, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel


      Microbiology Laboratory, Rabin Medical Center, Petach-Tikva, Israel.

      Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv; ; Medical Laboratory, Rabin Medical Center, Petach Tikva;


      Tel‐Aviv University The Sackler School of Medicine Tel Aviv Israel



      Haim Ben‐Zvi: Influence Statistics

      Sample of concepts for which Haim Ben‐Zvi is among the top experts in the world.
      Concept World rank
      cultures polymicrobial growth #2
      sinus surgery subsequent #2
      results386 cultures #2
      endoscopicguided cultures #2
      recurrent exacerbations crs #2
      bacteriology recurrent #3
      hospitalised adenovirus #4
      viral coinfection rates #4
      adenovirus healthy children #4
      hospitalised children adenovirus #4
      hospitalised picu #4
      adenovirus infection picu #4
      inadequate humoral response #5
      90 rcdi #5
      imc patient subgroups #5
      antis iqr #5
      recurrence rate clostridioides #5
      vaccine antis #5
      imc patients cdi #5
      recurrence imc #5
      immunosuppression humoral response #5
      rcdi 30 #5
      controls imc #5
      bnt162b2 vaccine hct #5
      recurrence rate cdi #5
      rcdi imc patients #5
      lateonset sepsis 24 #6
      proportion seronegative patients #6
      remdesivir nasopharyngeal #6
      propensityadjusted odds ratio #6
      nocardiosis matched #6
      pathogen crpo #6
      replacement urinary catheter #6
      pathogen crpo method #6
      95 275–1266 #6
      catheter replacement participants #6
      hospitalization cycle threshold #6
      seropositivity endpoint #6
      flt measurements control #6
      remdesivir groups #6
      4 groups types #6
      nocardiosis adrenal #6
      pathogens frequency domain #6
      groups remdesivir treatment #6
      sickappearance #6
      275–1266 0001 #6
      correlates nocardiosis #6
      clinical correlates nocardiosis #6
      antibiotic discontinuation 24 #6
      fd fluorescence lifetime #6


      Prominent publications by Haim Ben‐Zvi

      KOL-Index: 12951

      Importance: Patients with cancer undergoing treatment are at high risk of COVID-19 following SARS-CoV-2 infection; however, their ability to produce an adequate antibody response to messenger RNA SARS-CoV-2 vaccines is unclear.

      Objective: To evaluate rates of antispike (anti-S) antibody response to a BNT162b2 vaccine in patients with cancer who are undergoing systemic treatment vs healthy controls.

      Design, Setting, and Participants: This prospective cohort study included 102 adult ...

      Known for Patients Cancer | Messenger Rna | Bnt162b2 Vaccine | Igg Titers | Adequate Antibody Response
      KOL-Index: 9675

      The current guidelines recommend culture and antibiotic susceptibility testing of Helicobacter pylori following two failed eradication attempts. Where testing is unavailable, epidemiological data for secondary H. pylori resistance are essential to allow for the rational use of antibiotics. The aim of this study was to describe the temporal changes in antibiotic resistance among adults previously treated for H. pylori infections and to identify predictors of resistance. Between 2007 and ...

      Known for Helicobacter Pylori | Antibiotic Resistance | Clarithromycin Levofloxacin | Susceptibility Testing | Current Guidelines
      KOL-Index: 9282

      OBJECTIVES: We aimed to evaluate the rates of antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine among kidney transplant recipients, and to identify factors associated with reduced immunogenicity.

      METHODS: This was a prospective cohort study including consecutive kidney transplant recipients in a single referral transplant centre. Participants were tested for anti-spike (anti-S) antibodies 2-4 weeks after a second vaccine dose. Primary outcome ...

      Known for Antibody Response | Kidney Transplant | Prospective Cohort Study | Mrna Vaccine | Immunosuppression Level
      KOL-Index: 7339

      Several studies have shown an association between exposure to statins and favorable clinical outcomes for various types of infections. We aimed to assess the impact of statin use on mortality, disease severity and complications among hospitalized patients with Clostridium difficile infection (CDI). Data were analyzed from a retrospectively collected database of 499 patients diagnosed with CDI during 2009–2014. We compared infection outcomes between 178 statin (36 %) users and 321 (64 %) ...

      Known for Clostridium Difficile Infection | Cdi Statin | Aged Mortality | Humans Hydroxymethylglutaryl | Reductase Inhibitors
      KOL-Index: 7079

      OBJECTIVE: Clostridioides difficile infection (CDI) may pose a serious threat to immunocompromised patients (IMC). Herein, we evaluated the clinical outcomes of IMC patients with CDI.

      METHODS: All consecutive hospitalized patients between January 1, 2013 and December 31, 2018 with laboratory confirmed CDI were included in the study. Subjects were divided into two groups: IMC patients and controls. Primary outcome was the recurrence rate of CDI (rCDI) at 30 and 90 days after the first CDI ...

      Known for Difficile Infection | Cdi Rcdi | Recurrence Rate | Odds Ratios | Antibodies Clostridioides
      KOL-Index: 6975

      BACKGROUND: Necrotizing fasciitis (NF) is a life-threatening soft tissue infection. It is usually caused by Streptococcus pyogenes and other Gram-positive bacteria. Several reports, however, emphasize the importance of Gram-negative rods in this infection.

      METHODS: We retrospectively studied all cases of monomicrobial necrotizing fasciitis hospitalized in our center during the years 2002-2012. We compared clinical characteristics and outcomes of patients with Gram-negative versus ...

      Known for Necrotizing Fasciitis | Single Center | Gram Negative | Clinical Characteristics | Bacterial Infections
      KOL-Index: 6934

      Polymerase chain reaction (PCR) for the diagnosis of Clostridium difficile infection (CDI) might result in overdiagnosis. The clinical outcomes of symptomatic CDI patients diagnosed by PCR remain uncertain. We aimed to determine whether patients whose diagnosis of CDI was based on PCR had different characteristics and clinical outcomes than those diagnosed by toxin immunoassay. Consecutive CDI patients, hospitalized at Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel, ...

      Known for Clostridium Difficile Infection | Diagnosis Cdi | Toxin Immunoassay | Patients Pcr | Polymerase Chain
      KOL-Index: 6668

      Background: Catheter associated urinary tract infection (CAUTI) is the most common healthcare-associated acquired infection. We aimed to describe the short- and long-term survival of patients with CAUTI and the impact of the empirical antibiotic treatment on survival rates.

      Methods: In this prospective observational study we included consecutive adult patients with a chronic indwelling catheter-associated UTI and sepsis hospitalized in medical departments. The primary outcomes were ...

      Known for Antibiotic Treatment | Urinary Tract | Patients Cauti | Hazard Ratio | Catheter Infections
      KOL-Index: 6490

      Secondary bacterial infections are a potentially fatal complication of influenza infection. We aimed to define the impact of secondary bacterial infections on the clinical course and mortality in coronavirus disease 2019 (COVID-19) patients by comparison with influenza patients. COVID-19 (n = 642) and influenza (n = 742) patients, admitted to a large tertiary center in Israel and for whom blood or sputum culture had been taken were selected for this study. Bacterial culture results, ...

      Known for Secondary Bacterial Infection | Gram Positive | Aged Covid19 | Negative Bacterial | Influenza Patients
      KOL-Index: 5885

      Summary The SARS-CoV-2 pandemic has been raging for over a year, creating global detrimental impact. The BNT162b2 mRNA vaccine has demonstrated high protection levels, yet apprehension exists that several variants of concerns (VOCs) can surmount the immune defenses generated by the vaccines. Neutralization assays have revealed some reduction in neutralization of VOCs B.1.1.7 and B.1.351, but the relevance of these assays in real life remains unclear. We performed a case-control study ...

      Known for Vaccinated Individuals | Bnt162b2 Mrna | Sarscov2 Variants | Vaccine Breakthrough | Vocs B117
      KOL-Index: 5735

      INTRODUCTION: Respiratory syncytial virus (RSV) is considered a major pathogen that causes acute influenza-like illness. The objective of this study was to compare the clinical outcomes of patients with laboratory-confirmed RSV and patients with influenza infection.

      METHODS: Adults hospitalized in Beilinson Hospital (October 2017-April 2018) with laboratory-confirmed RSV or influenza were included. The primary outcome was the composite of RSV/influenza complications: 30-day mortality, ...

      Known for Hospitalized Adults | Respiratory Syncytial Virus | Patients Influenza | Mechanical Ventilation | Rsv Infection
      KOL-Index: 5651

      The BNT162b2 mRNA vaccine is highly effective against SARS-CoV-2. However, apprehension exists that variants of concern (VOCs) may evade vaccine protection, due to evidence of reduced neutralization of the VOCs B.1.1.7 and B.1.351 by vaccine sera in laboratory assays. We performed a matched cohort study to examine the distribution of VOCs in infections of BNT162b2 mRNA vaccinees from Clalit Health Services (Israel) using viral genomic sequencing, and hypothesized that if vaccine ...

      Known for Concern Vocs | Viral Variants | Vaccines Child Child | Vaccine Effectiveness | Vaccinated Individuals
      KOL-Index: 5250

      OBJECTIVES: The effectiveness of remdesivir, a Food and Drug Administration-approved drug for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been repeatedly questioned during the current coronavirus disease 2019 (COVID-19) pandemic. Most of the recently reported studies were randomized controlled multicentre clinical trials. Our goal was to test the efficiency of remdesivir in reducing nasopharyngeal viral load and hospitalization length in a real-life setting in ...

      Known for Viral Load | Remdesivir Treatment | Cov2 Severity | Cycle Threshold | Real Life
      KOL-Index: 4984

      BackgroundCharacteristics of hepatitis B (HBV) and delta (HDV) coinfection in various geographical regions, including Israel, remain unclear. Here we studied HDV seroprevalence in Israel, assessed HDV/HBV viral loads, circulating genotypes and hepatitis delta antigen (HDAg) conservation.MethodsSerological anti HDV IgG results from 8969 HBsAg positive individuals tested in 2010-2015 were retrospectively analyzed to determine HDV seroprevalence. In a cohort of HBV/HDV coinfected (n=58) and ...

      Known for Hbv Hdv | Hepatitis Virus | Rna Viral | Positive Patients | Female Genotype
      KOL-Index: 4276

      INTRODUCTION: Stable chronic obstructive pulmonary disease (COPD) patients often have lower airway bacterial colonization (ABC) which may modulate exacerbation frequency. Data regarding the association between ABC and post-procedural COPD exacerbations following bronchoscopic lung volume reduction (BLVR) are scant.

      OBJECTIVES: Our aim was to explore the correlation among ABC, serum C-reactive protein (CRP) level and the risk of COPD exacerbation within a month following BLVR.

      METHODS: ...

      Known for Chronic Obstructive | Pulmonary Disease | Bacterial Colonization | Copd Patients | Volume Reduction

      Key People For Bnt162b2 Vaccine

      Top KOLs in the world
      Kena A Swanson
      bnt162b2 vaccine neutralizing antibodies 6 months
      Philip Ralph Dormitzer
      neutralizing antibodies influenza virus vaccine efficacy
      Warren Vincent Kalina
      neutralizing antibodies 6 months clinical validation
      Kenneth J Koury
      chronic hepatitis peginterferon ribavirin 6 months
      Stephen P Lockhart
      conjugate vaccine challenge dose acute otitis media
      Alejandra C Gurtman
      conjugate vaccine staphylococcus aureus valent pneumococcal

      Haim Ben‐Zvi:Expert Impact

      Concepts for whichHaim Ben‐Zvihas direct influence:Bnt162b2 vaccine,  Chronic rhinosinusitis,  Difficile infection,  Kidney transplant recipients,  Viral load,  Immunosuppression reduction,  Clostridioides difficile infection,  Clostridium difficile infection.

      Haim Ben‐Zvi:KOL impact

      Concepts related to the work of other authors for whichfor which Haim Ben‐Zvi has influence:Antibody response,  Patients cancer,  Transplant recipients,  Covid19 vaccines,  Neutralizing antibodies,  Viral load,  Bnt162b2 vaccine.



      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Rabin Medical Center, Microbiology lab, Petah Tikva, Israel | Microbiology Laboratory, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel | Microbiology lab, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel | Microbiology Lab

    Download on the App StoreGet it on Google Play

    Copyright © 2023 - KOL means Key Opinion Leaders .

    KOL does not provide medical advice, diagnosis or treatment.